Repare Therapeutics Inc (RPTX) — Cash Flow-to-Debt Ratio
Repare Therapeutics Inc (RPTX) has a Cash Flow-to-Debt Ratio of 0.23x as of September 2025, meaning its operating cash flow of $2.65 Million could theoretically repay 0% of its total liabilities ($11.62 Million) in one year. Explore Repare Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Repare Therapeutics Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Repare Therapeutics Inc across 7 annual periods. Also explore RPTX total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Repare Therapeutics Inc (2018–2024)
Year-by-year debt coverage analysis for Repare Therapeutics Inc. For market capitalisation and broader financial context, see Repare Therapeutics Inc stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.01x | $-76.44 Million | $25.38 Million | ▲ +0.9% |
| 2023 | -3.04x | $-127.16 Million | $41.82 Million | ▼ -79948.9% |
| 2022 | 0.00x | $322.00K | $84.56 Million | ▲ +100.4% |
| 2021 | -1.07x | $-85.80 Million | $80.29 Million | ▼ -1133.9% |
| 2020 | -0.09x | $-6.08 Million | $70.26 Million | ▲ +94.0% |
| 2019 | -1.44x | $-18.43 Million | $12.83 Million | ▼ -313.4% |
| 2018 | -0.35x | $-12.62 Million | $36.31 Million | — |